Stay updated on Amgen Press Releases

Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Amgen Press Releases page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Multiple press release entries have been removed from the Newsroom > Press Releases listing, including items such as the 01.08.2025 J.P. Morgan Healthcare Conference presentation, FDA approvals, and quarterly results announcements. This reduces the amount of visible press information and historical records on the page.
    Difference
    21%
    Check dated 2025-12-01T16:39:52.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new press release entry titled 'FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER' dated 11.19.2025 has been added to the Newsroom press releases page.
    Difference
    0.4%
    Check dated 2025-11-24T11:44:06.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Two new press releases were added to Amgen's Newsroom: AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS (11.04.2025) and AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL (11.08.2025). A November 2025 section header also appears on the page.
    Difference
    1%
    Check dated 2025-11-10T02:36:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Three new press releases were added: AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS; AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025; AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND.
    Difference
    9%
    Check dated 2025-11-03T00:54:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added three new major items: Amgen financial results webcast, FDA approval of Lumakras in combination with Vectibix for chemo-refractory KRAS G12C metastatic colorectal cancer, and Amgen’s presentation at the 43rd annual J.P. Morgan Healthcare Conference.
    Difference
    100%
    Check dated 2025-10-19T16:07:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    - Removed three dated items: a 2025 financial results webcast, a 2025 drug approval press release, and a 2025 conference presentation notice. This trims time-sensitive, high-importance content without introducing new information.
    Difference
    100%
    Check dated 2025-10-12T11:46:48.000Z thumbnail image

Stay in the know with updates to Amgen Press Releases

Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.